Get started
Author

Anna Maria Vandone

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
2010 · Isabella Castellano, Elena Allia, et al. · Breast Cancer Research and Treatment · 192
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience
2011 · A.M. Vandone, M. Donadio, et al. · Annals of Oncology · 167
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019 · M.E. Cazzaniga, G. Pinotti, et al. · The Breast · 56
Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
2006 · M. Ardine, D. Generali, et al. · Annals of Oncology · 51
PDF
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
2016 · Ornella Garrone, Filippo Montemurro, et al. · SpringerPlus · 37
PDF
A simple and reproducible prognostic index in luminal ER-positive breast cancers
2013 · I. Castellano, L. Chiusa, et al. · Annals of Oncology · 28
PDF
Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model
2012 · S. Saracino, R. A. Canuto, et al. · Journal of Oral Pathology and Medicine · 27
PDF
Eribulin in Advanced Breast Cancer: Safety, Efficacy and New Perspectives
2017 · Ornella Garrone, Emanuela Miraglio, et al. · Future Oncology · 21
Exploratory analysis of circulating cytokines in patients with metastatic breast cancer treated with eribulin: the TRANSERI-GONO (Gruppo Oncologico del Nord Ovest) study
2020 · Ornella Garrone, Andrea Michelotti, et al. · ESMO Open · 19
PDF
Personalized management of patients with solid cancers
2012 · Ahmad Awada, Anna M. Vandone, et al. · Current Opinion in Oncology · 19
Patients with cancer and hospital admissions: disease trajectory and strategic choices
2023 · Gianmauro Numico, Rachele Ferrua, et al. · BMJ Supportive & Palliative Care · 6
Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC
2004 · R. Buosi, S. Poletti, et al. · Journal of Clinical Oncology · 5
290P From the CLEOPATRA study to real life: Final results from the G.O.N.O. SUPER trial
2020 · O. Garrone, T. Giarratano, et al. · Annals of Oncology · 2
PDF
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study.
2017 · Marina Elena Cazzaniga, Virginia Casadei, et al. · Journal of Clinical Oncology · 2
Metronomic oral cyclophosphamide (CTX) in patients (pts) with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC)
2016 · E. Fea, P. Vanella, et al. · Annals of Oncology · 2
Abstract GS3-02: Fertility and ovarian function preservation in premenopausal women with early breast cancer: results from the multicenter prospective PREgnancy and FERtility (PREFER) study
2026 · M. Lambertini, E. Blondeaux, et al. · Clinical Cancer Research · 1
Postoperative radiotherapy for stage IV breast cancer following primary tumor removal: Systematic review and meta-analysis
2025 · Anna Maria Merlotti, Stefania Martini, et al. · Tumori Journal · 1
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy
2020 · Ornella Garrone, Nerina Denaro, et al. · Tumori Journal · 1
Melanoma
2019 · Marcella Occelli, Anna M. Vandone, et al. · Anti-Cancer Drugs · 1
Breast cancer with synchronous and metachronous metastatic spreading. A single institution experience
2016 · A.M. Vandone, O. Garrone, et al. · Annals of Oncology · 1
PDF
3088 Increase and decrease of jaw osteonecrosis (ONJ) in patients treated with intravenous bisphosphonates (BP): impact of preventive measures and reduced prescriptions in the experience of the “Rete Oncologica di Piemonte e Valle d'Aosta” ONJ study group
2009 · V. Fusco, C. Ortega, et al. · European Journal of Cancer Supplements · 1
1131 POSTER Osteonecrosis of the jaw (ONJ) in patients treated with Bisphosphonates (BP): the experience of the "Rete Oncologica di Piemonte e Valle D'Aosta" (North-Western Italy)
2007 · V. Fusco, M. Aglietta, et al. · European Journal of Cancer Supplements · 1
Abstract PS2-09-17: Comprehensive peripheral immune profiling in Triple Negative Breast Cancer (TNBC) links immune cell dynamics to therapeutic response and irAEs: insight from the IRIS Study
2026 · L. Negrini, V. Martini, et al. · Clinical Cancer Research
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation
2025 · Gianmauro Numico, Elena Fea, et al. · Tumori Journal
318P PD-L1+ tumoral extracellular vesicles as biomarkers of immune-related toxicities in TNBC: Preliminary results from the IRIS study
2025 · T.L. Landolfo, V. Martini, et al. · Annals of Oncology
Works count: 45
Citation count: 641
H-index: 10
I10-index: 10
Year
Topic
Type